Methods to Study Lipid Alterations in Neutrophils and the Subsequent Formation of Neutrophil Extracellular Traps
March 29th, 2017
Lipids are known to play an important role in cellular functions. Here, we describe a method to determine the lipid composition of neutrophils, with emphasis on the cholesterol level, by using both HPTLC and HPLC to gain a better understanding of the underlying mechanisms of neutrophil extracellular trap formation.
Overview
This article presents a method for analyzing the lipid composition of neutrophils, focusing on cholesterol levels. The approach utilizes HPTLC and HPLC techniques to enhance understanding of neutrophil extracellular trap (NET) formation mechanisms.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Immunology
Background
- Lipids are crucial for various cellular functions.
- Neutrophils play a significant role in immune response.
- NET formation is a key process in neutrophil function.
- Understanding lipid composition can provide insights into neutrophil behavior.
Purpose of Study
- To investigate lipid composition changes in neutrophils.
- To explore the role of lipids in NET formation.
- To provide a straightforward protocol for lipid analysis.
Methods Used
- Thin layer chromatography (HPTLC)
- High-performance liquid chromatography (HPLC)
- Isolation of human blood-derived neutrophils
- Preparation of cells for lipid analysis
Main Results
- Detailed lipid profiles of neutrophils were obtained.
- Cholesterol levels were specifically analyzed.
- Insights into the mechanisms of NET formation were gained.
- The method proved to be user-friendly and effective.
Conclusions
- The study enhances understanding of lipid roles in neutrophils.
- It provides a valuable protocol for future research.
- Further exploration of lipid composition can inform immunological studies.
Frequently Asked Questions
Executive Industry Relevance
Quantitative lipid profiling in neutrophils using HPTLC and HPLC enables mechanistic de-risking of innate immune responses relevant to infection and inflammation. This workflow supports predictive confidence in target validation for pathways involving neutrophil extracellular trap (NET) formation. Integrating lipidomic analysis at the discovery stage informs portfolio decisions on immunomodulatory targets and host-pathogen interaction mechanisms.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of lipid-dependent mechanisms in neutrophil function and NET formation.
- Supports biological de-risking by quantifying cholesterol and other lipid alterations upon pharmacological treatment.
- Facilitates functional target validation for innate immune pathways implicated in infection control.
- Provides mechanistic insight to prioritize or deprioritize immune-modulating targets.
Screening & Assay Development
- Establishes validated lipid quantification assays for neutrophil samples using HPTLC and HPLC.
- Delivers reproducible, quantitative outputs for cholesterol and lipid content across experimental conditions.
- Enables standardization of sample preparation and analytical workflows for downstream screening.
- Supports assay readiness for evaluating compound effects on neutrophil lipid composition.
Translational & Preclinical Research
- Aligns lipidomic changes with disease-relevant immune responses in preclinical models.
- Provides continuity from discovery-stage mechanistic studies to translational biomarker identification.
- Informs risk-adjusted advancement of immunomodulatory candidates targeting NET pathways.
- Supports predictive de-risking for host-pathogen interaction studies.
Pipeline & Workflow Integration
This lipid analysis method integrates into the discovery-to-preclinical continuum for immunology and infectious disease programs.
- Discovery Biology: Quantifies lipid alterations to clarify mechanistic hypotheses in neutrophil activation and NET release.
- Screening: Provides standardized, quantitative lipid readouts for compound evaluation and pathway interrogation.
- Analytics: Delivers robust cholesterol and lipid measurements for statistical comparison across experimental arms.
- Translational Research: Bridges mechanistic lipid findings to preclinical biomarker strategies when supported by disease models.
- Enterprise Reuse: Offers a reusable analytical platform for lipid profiling in diverse immune cell studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune pathway validation and reduces mechanistic ambiguity in NET research.
- Operational Value: Standardizes lipid analysis workflows for reproducibility and scalability across R&D teams.
- Strategic Value: Enables informed go/no-go decisions for immunomodulatory targets based on quantitative lipid data.
- Portfolio Impact: Supports risk-adjusted prioritization of discovery and preclinical assets targeting innate immunity.
Implementation Considerations
- Requires expertise in lipid extraction, HPTLC, and HPLC operation and analysis.
- Demands access to chromatography instrumentation and validated analytical protocols.
- Necessitates cross-team standardization for sample handling and data interpretation.
- May require adaptation for different immune cell types or disease models.
- Must comply with biosafety and ethical requirements for primary human cell work.
Biopharma FAQs
Chapters in this video
0:05
Title
1:14
Isolation of Human Blood-derived Neutrophils by Density Gradient Centrifugation
3:59
Isolate the Lipids from the Human Peripheral Blood-derived Neutrophils
5:33
High Performance Thin Layer Chromatography (HPTLC) to Semi-quantify the Amount of Lipids
7:53
High Performance Liquid Chromatography (HPLC) to Quantify the Amount of Cholesterol
8:48
Results: Isolation of Human Blood-derived Neutrophils and Subsequent Lipid Analysis
9:33
Conclusion
